Are GLP-1 refill reminders marketing under HIPAA?

A reminder to a patient to refill a GLP-1 medication they are currently taking is not considered marketing under HIPAA . As long as a third party isn’t paying for the communication above the cost of communication . It crosses into marketing territory if you suggest a different medication to the patient or if the drug manufacturer or another party covers costs beyond what it takes to send the communication.